CLINICAL_TRIALS
research
· 2015-04-22
Clinical Trial Update: Faecal Microbiota Transplantation in Irritable Bowel Syndrome [Phase 2]
Summary
An ongoing Phase 2 trial evaluating faecal microbiota transplantation for irritable bowel syndrome; current status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University College Cork | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: UNKNOWN